National Comprehensive Cancer Network



About NCCN

Multiple Myeloma/Systemic Light Chain Amyloidosis/Waldenstrm's Macroglobulinemia Panel - Disclosures as of 12/20/2013

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Melissa Alsina, MD

None

Onyx Pharmaceuticals, Inc.

None

None

5/6/2014

Kenneth C. Anderson, MD

None

Celgene Corporation;
Onyx Pharmaceuticals, Inc.;
Gilead Sciences;
sanofi-aventis U.S.

acetylon;
oncopep

acetylon;
oncopep

4/21/2014

William Bensinger, MD

Celgene Corporation;
Millennium Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation;
Onyx Pharmaceuticals, Inc.;
Pharmacyclics

Celgene Corporation;
Millennium Pharmaceuticals, Inc.

None

None

9/17/2014

J. Sybil Biermann, MD

None

None

None

None

5/2/2014

Jason C. Chandler, MD

None

Onyx Pharmaceuticals, Inc.

None

None

2/26/2013

Caitlin Costello, MD

None

None

None

None

2/21/2014

Benjamin Djulbegovic, MD, PhD

None

None

None

None

4/16/2014

Lauren Gallagher, RPh, PhD

None

None

None

None

6/4/2014

Cristina Gasparetto, MD

None

Celgene Corporation;
Celgene Corporation;
Millennium Pharmaceuticals, Inc.

None

None

5/6/2014

Kelly Godby, MD

None

None

None

None

10/7/2013

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

9/16/2014

Francisco Hernandez-Ilizaliturri, MD

None

Amgen Inc.;
Millennium Pharmaceuticals, Inc.;
Seattle Genetics

None

None

9/25/2014

Craig Hofmeister, MD, MPH

Celgene Corporation;
Millennium Pharmaceuticals, Inc.;
Onyx Pharmaceuticals, Inc.

Celgene Corporation;
Celgene Corporation

None

None

4/29/2014

Carol Ann Huff, MD

Geron;
Pharmacyclics

Celgene Corporation;
Novartis Pharmaceuticals Corporation

None

None

5/2/2014

Adetola Kassim, MD, MS

None

None

None

None

4/17/2014

Amrita Y. Krishnan, MD, FACP

None

Celgene Corporation;
Genentech, Inc.;
Jannsen Pharmaceutica Products, LP;
Millennium Pharmaceuticals, Inc.;
Onyx Pharmaceuticals, Inc.

Celgene Corporation;
Pharmacyclics

None

5/4/2014

Rashmi Kumar, PhD

None

None

None

None

11/7/2014

Michaela Liedtke, MD

None

None

None

None

5/6/2014

Matthew Lunning, DO

None

None

None

None

3/27/2014

Joan S. McClure, MS

None

None

None

None

6/20/2014

Noopur Raje, MD

Amgen Inc.;
Eli Lilly and Company;
Acetylon

Celgene Corporation;
Millennium Pharmaceuticals, Inc.;
Onyx Pharmaceuticals, Inc.

None

None

9/6/2013

Dorothy Shead, MS

None

None

None

None

8/7/2014

Seema Singhal, MD

Celgene Corporation;
Millennium Pharmaceuticals, Inc.;
Onyx Pharmaceuticals, Inc.

Celgene Corporation;
Millennium Pharmaceuticals, Inc.

None

None

5/20/2013

Clayton Smith, MD

None

None

None

None

12/16/2013

George Somlo, MD

None

Celgene Corporation;
Genentech, Inc.;
Genentech, Inc.;
Millennium Pharmaceuticals, Inc.;
Abraxane;
Roche Laboratories, Inc.;
Roche Laboratories, Inc.

None

None

7/17/2014

Keith Stockerl-Goldstein, MD

None

Celgene Corporation;
Millennium Pharmaceuticals, Inc.;
Onyx Pharmaceuticals, Inc.

None

None

5/23/2013

Steven P. Treon, MD, PhD

None

None

None

None

1/16/2014

Sarika Trikha, PharmD

None

None

None

None

11/11/2014

Donna M. Weber, MD

Merck & Co., Inc.;
Novartis Pharmaceuticals Corporation

None

None

None

9/26/2013

Joachim Yahalom, MD

None

None

None

None

8/18/2014